• 1
    Grant SA. The Holy Grail: long-acting local anaesthetics and liposomes. Best Practice & Research Clinical Anaesthesiology 2002; 16: 34552.
  • 2
    Kuzma PJ, Kline MD, Calkins MD, Staats PS. Progress in the development of ultra-long-acting local anesthetics. Regional Anesthesia 1997; 22: 54351.
  • 3
    Grant GJ, Barenholz Y, Bolotin EM, et al. A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology 2004; 101: 1337.
  • 4
    Grant SA, Nielsen KC, Greengrass RA, Steele SM, Klein SM. Continuous peripheral nerve block for ambulatory surgery. Regional Anesthesia and Pain Medicine 2001; 26: 20914.
  • 5
    Masters DB, Berde CB, Dutta SK, et al. Prolonged regional nerve blockade by controlled release of local anesthetic from a biodegradable polymer matrix. Anesthesiology 1993; 79: 3406.
  • 6
    Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesthesia and Analgesia 2011; 113: 90425.
  • 7
    Fournier R, Faust A, Chassot O, Gamulin Z. Levobupivacaine 0.5% provides longer analgesia after sciatic nerve block using the Labat approach than the same dose of ropivacaine in foot and ankle surgery. Anesthesia and Analgesia 2010; 110: 14869.
  • 8
    Fanelli G, Casati A, Beccaria P, et al. A double-blind comparison of ropivacaine, bupivacaine, and mepivacaine during sciatic and femoral nerve blockade. Anesthesia and Analgesia 1998; 87: 597600.
  • 9
    Casati A, Fanelli G, Albertin A, et al. Interscalene brachial plexus anesthesia with either 0.5% ropivacaine or 0.5% bupivacaine. Minerva Anestesiologica 2000; 66: 3944.
  • 10
    Casati A, Fanelli G, Cappelleri G, et al. A clinical comparison of ropivacaine 0.75%, ropivacaine 1% or bupivacaine 0.5% for interscalene brachial plexus anaesthesia. European Journal of Anaesthesiology 1999; 16: 7849.
  • 11
    Liisanantti O, Luukkonen J, Rosenberg PH. High-dose bupivacaine, levobupivacaine and ropivacaine in axillary brachial plexus block. Acta Anaesthesiologica Scandinavica 2004; 48: 6016.
  • 12
    Cox CR, Checketts MR, Mackenzie N, Scott NB, Bannister J. Comparison of S(-)-bupivacaine with racemic (RS)-bupivacaine in supraclavicular brachial plexus block. British Journal of Anaesthesia 1998; 80: 5948.
  • 13
    Columb M, MacLennan K. Local anaesthetic agents. Anaesthesia and Intensive Care Medicine 2007; 8: 15962.
  • 14
    Aberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacologica et Toxicologica (Copenh) 1972; 31: 27386.
  • 15
    Thomas JM, Schug SA. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions. Clinical Pharmacokinetics 1999; 36: 6783.
  • 16
    Bardsley H, Gristwood R, Baker H, Watson N, Nimmo W. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. British Journal of Clinical Pharmacology 1998; 46: 2459.
  • 17
    Casati A, Santorsola R, Aldegheri G, et al. Intraoperative epidural anesthesia and postoperative analgesia with levobupivacaine for major orthopedic surgery: a double-blind, randomized comparison of racemic bupivacaine and ropivacaine. Journal of Clinical Anesthesia 2003; 15: 12631.
  • 18
    Sites BD, Bertrand ML, Gallagher JD. An abnormal clinical course of an ultrasound-guided supraclavicular brachial plexus block using 0.375% bupivacaine. Journal of Clinical Anesthesia 2006; 18: 44951.
  • 19
    Adams HJ, Blair MR Jr, Takman BH. The local anesthetic activity of tetrodotoxin alone and in combination with vasoconstrictors and local anesthetics. Anesthesia and Analgesia 1976; 55: 56873.
  • 20
    Kohane DS, Lu NT, Gokgol-Kline AC, et al. The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in vivo. Regional Anesthesia and Pain Medicine 2000; 25: 529.
  • 21
    Kohane DS, Yieh J, Lu NT, Langer R, Strichartz GR, Berde CB. A re-examination of tetrodotoxin for prolonged duration local anesthesia. Anesthesiology 1998; 89: 11931.
  • 22
    Rodriguez-Navarro AJ, Berde CB, Wiedmaier G, et al. Comparison of neosaxitoxin versus bupivacaine via port infiltration for postoperative analgesia following laparoscopic cholecystectomy: a randomized, double-blind trial. Regional Anesthesia and Pain Medicine 2011; 36: 1039.
  • 23
    Rodriguez-Navarro AJ, Lagos M, Figueroa C, et al. Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: development of a long-acting pain blocker. Neurotoxicity Research 2009; 16: 40815.
  • 24
    Le Corre P, Estebe JP, Clement R, et al. Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep. International Journal of Pharmaceutics 2002; 238: 191203.
  • 25
    Shikanov A, Domb AJ, Weiniger CF. Long acting local anesthetic-polymer formulation to prolong the effect of analgesia. Journal of Controlled Release 2007; 117: 97103.
  • 26
    Sokolsky-Papkov M, Golovanevski L, Domb AJ, Weiniger CF. Prolonged local anesthetic action through slow release from poly (lactic acid co castor oil). Pharmaceutical Research 2009; 26: 329.
  • 27
    Weiniger CF, Golovanevski M, Sokolsky-Papkov M, Domb AJ. Review of prolonged local anesthetic action. Expert Opinion on Drug Delivery 2010; 7: 73752.
  • 28
    Sokolsky-Papkov M, Golovanevski L, Domb AJ, Weiniger CF. Poly(DL:lactic acid-castor oil) 3:7-bupivacaine formulation: reducing burst effect prolongs efficacy in vivo. Journal of Pharmaceutical Sciences 2010; 99: 27328.
  • 29
    Dollo G, Thompson DO, Le Corre P, et al. Inclusion complexation of amide-typed local anesthetics with b-cyclodextrin and its derivatives. III. Biopharmaceutics of bupivacaine-SBE7-bCD complex following percutaneous sciatic nerve administration in rabbits. International Journal of Pharmaceutics 1998; 164: 119.
  • 30
    Ross SB, Sandberg R, Akerman BA, Domeij KE, Stening G, Svensson S. Cyclizing compounds. 3. Local anesthetic action of N-(omega-haloalkyl)-N-methylaminoaceto-2,6-xylidides. Journal of Medicinal Chemistry 1973; 16: 78790.
  • 31
    Langerman L, Golomb E, Benita S. Spinal anesthesia: significant prolongation of the pharmacologic effect of tetracaine with lipid solution of the agent. Anesthesiology 1991; 74: 1057.
  • 32
    Korsten HH, Ackerman EW, Grouls RJ, et al. Long-lasting epidural sensory blockade by n-butyl-p-aminobenzoate in the terminally ill intractable cancer pain patient. Anesthesiology 1991; 75: 95060.
  • 33
    Jia X, Colombo G, Padera R, Langer R, Kohane DS. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials 2004; 25: 4797804.
  • 34
    Bergese SD, Onel E, Morren M, Morganroth J. Bupivacaine extended-release liposome injection exhibits a favorable cardiac safety profile. Regional Anesthesia and Pain Medicine 2012; 37: 14551.
  • 35
    Smoot JD, Bergese SD, Onel E, Williams HT, Hedden W. The efficacy and safety of depoFoam Bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammaplasty: a randomized, double-blind, active-control study. Aesthetic Surgery Journal 2012; 32: 6976.
  • 36
    Minkowitz HS, Onel E, Patronella CK, Smoot JD. A two-year observational study assessing the safety of DepoFoam Bupivacaine after augmentation mammaplasty. Aesthetic Surgery Journal 2012; 32: 18693.
  • 37
    Wang CF, Pancaro C, Gerner P, Strichartz G. Prolonged suppression of postincisional pain by a slow-release formulation of lidocaine. Anesthesiology 2011; 114: 13549.
  • 38
    Le Corre P, Rytting JH, Gajan V, Chevanne F, Le Verge R. In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co-glycolide) microspheres. Journal of Microencapsulation 1997; 14: 24355.
  • 39
    Gruner SM, Lenk RP, Janoff AS, Ostro MJ. Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles. Biochemistry 1985; 24: 283342.
  • 40
    Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. Journal of Pharmaceutical Sciences 2001; 90: 66780.
  • 41
    Grant GJ, Barenholz Y, Piskoun B, Bansinath M, Turndorf H, Bolotin EM. DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice. Pharmaceutical Research 2001; 18: 33643.
  • 42
    Malinovsky JM, Le Corre P, Meunier JF, et al. A dose-response study of epidural liposomal bupivacaine in rabbits. Journal of Controlled Release 1999; 60: 1119.
  • 43
    Boogaerts J, Declercq A, Lafont N, et al. Toxicity of bupivacaine encapsulated into liposomes and injected intravenously: comparison with plain solutions. Anesthesia and Analgesia 1993; 76: 5535.
  • 44
    Mowat JJ, Mok MJ, MacLeod BA, Madden TD. Liposomal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient. Anesthesiology 1996; 85: 63543.
  • 45
    Boogaerts JG, Lafont ND, Luo H, Legros FJ. Plasma concentrations of bupivacaine after brachial plexus administration of liposome-associated and plain solutions to rabbits. Canadian Journal of Anesthesia 1993; 40: 12014.
  • 46
    Blanco MD, Bernardo MV, Gomez C, Muniz E, Teijon JM. Bupivacaine-loaded comatrix formed by albumin microspheres included in a poly(lactide-co-glycolide) film: in vivo biocompatibility and drug release studies. Biomaterials 1999; 20: 191924.
  • 47
    Hall SM, Gregson NA. The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. Journal of Cell Science 1971; 9: 76989.
  • 48
    Malinovsky JM, Benhamou D, Alafandy M, et al. Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits. Anesthesia and Analgesia 1997; 85: 13316.
  • 49
    Dyhre H, Soderberg L, Bjorkman S, Carlsson C. Local anesthetics in lipid-depot formulations--neurotoxicity in relation to duration of effect in a rat model. Regional Anesthesia and Pain Medicine 2006; 31: 4018.
  • 50
    Soderberg L, Dyhre H, Roth B, Bjorkman S. Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: comparison of in vitro, in vivo, and effect kinetics. Anesthesiology 2006; 104: 11021.
  • 51
    Jain R, Shah NH, Malick AW, Rhodes CT. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Development and Industrial Pharmacy 1998; 24: 70327.
  • 52
    Klose D, Siepmann F, Elkharraz K, Siepmann J. PLGA-based drug delivery systems: importance of the type of drug and device geometry. International Journal of Pharmaceutics 2008; 354: 95103.
  • 53
    Bernardo MV, Blanco MD, Olmo R, JM T. Delivery of bupivacaine included in poly(acrylamide-comonomethyl itaconate) hydrogels as a function of the pH swelling medium. Journal of Applied Polymer Science 2002; 86: 32734.
  • 54
    Iida H, Watanabe Y, Dohi S, Ishiyama T. Direct effects of ropivacaine and bupivacaine on spinal pial vessels in canine. Assessment with closed spinal window technique. Anesthesiology 1997; 87: 7581.
  • 55
    Curley J, Castillo J, Hotz J, et al. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996; 84: 140110.
  • 56
    Maniar M, Domb A, Haffer A, Shah J. Controlled release of a local anesthetic from fatty acid dimer based polyanhydride. Journal of Controlled Release 1994; 30: 2339.
  • 57
    Kohane DS, Lipp M, Kinney RC, et al. Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium. Journal of Biomedical Materials Research Part A 2002; 59: 4509.
  • 58
    Colombo G, Langer R, Kohane DS. Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve. Journal of Biomedical Materials Research Part A 2004; 68: 6519.
  • 59
    Salonia A, Crescenti A, Suardi N, et al. General versus spinal anesthesia in patients undergoing radical retropubic prostatectomy: results of a prospective, randomized study. Urology 2004; 64: 95100.
  • 60
    Padera RF, Tse JY, Bellas E, Kohane DS. Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle and Nerve 2006; 34: 74753.
  • 61
    Epstein-Barash H, Shichor I, Kwon AH, et al. Prolonged duration local anesthesia with minimal toxicity. Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 712530.
  • 62
    Grant GJ, Piskoun B, Bansinath M. Analgesic duration and kinetics of liposomal bupivacaine after subcutaneous injection in mice. Clinical and Experimental Pharmacology and Physiology 2003; 30: 9668.
  • 63
    Grant GJ, Vermeulen K, Langerman L, Zakowski M, Turndorf H. Prolonged analgesia with liposomal bupivacaine in a mouse model. Regional Anesthesia 1994; 19: 2649.
  • 64
    Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 7788.
  • 65
    Boogaerts JG, Lafont ND, Declercq AG, et al. Epidural administration of liposome-associated bupivacaine for the management of postsurgical pain: a first study. Journal of Clinical Anesthesia 1994; 6: 31520.
  • 66
    Mashimo T, Uchida I, Pak M, et al. Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine. Anesthesia and Analgesia 1992; 74: 82734.
  • 67
    Masters DB, Berde CB, Dutta S, Turek T, Langer R. Sustained local anesthetic release from bioerodible polymer matrices: a potential method for prolonged regional anesthesia. Pharmaceutical Research 1993; 10: 152732.
  • 68
    de Araujo DR, Cereda CM, Brunetto GB, Pinto LM, Santana MH, de Paula E. Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice. Canadian Journal of Anesthesia 2004; 51: 56672.
  • 69
    de Araujo DR, Cereda CM, Brunetto GB, et al. Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine. Journal of Pharmacy and Pharmacology 2008; 60: 144957.
  • 70
    Boogaerts JG, Lafont ND, Carlino S, et al. Biodistribution of liposome-associated bupivacaine after extradural administration to rabbits. British Journal of Anaesthesia 1995; 75: 31925.
  • 71
    Malinovsky JM, Bernard JM, Le Corre P, Faivre A, Chatal JF, Pinaud M. Extradural bupivacaine-loaded microspheres and spinal cord blood flow in the chronically instrumented rabbit. Clinical Physiology 1997; 17: 36170.
  • 72
    Kohane DS, Smith SE, Louis DN, et al. Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain 2003; 104: 41521.
  • 73
    Vaisman B, Motiei M, Nyska A, Domb AJ. Biocompatibility and safety evaluation of a ricinoleic acid-based poly(ester-anhydride) copolymer after implantation in rats. Journal of Biomedical Materials Research Part A 2010; 92: 41931.
  • 74
    Cohen R, Kanaan H, Grant GJ, Barenholz Y. Prolonged analgesia from Bupisome and Bupigel formulations: from design and fabrication to improved stability. Journal of Controlled Release 2011; ????: ????????. Dec 30; doi 10.1016/j.jconrel.2011.12.030.
  • 75
    Barenholz Y. Relevancy of drug loading to liposomal formulation therapeutic efficacy. Journal of Liposome Research 2003; 13: 18.
  • 76
    Maurer N, Fenske DB, Cullis PR. Developments in liposomal drug delivery systems. Expert Opinion on Biological Therapy 2001; 1: 92347.
  • 77
    Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine 2006; 1: 297315.
  • 78
    Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery 2005; 4: 14560.
  • 79
    Holte K, Werner MU, Lacouture PG, Kehlet H. Dexamethasone prolongs local analgesia after subcutaneous infiltration of bupivacaine microcapsules in human volunteers. Anesthesiology 2002; 96: 13315.
  • 80
    Verma S, Garkhal K, Mittal A, Kumar N. Biodegradable Polymers for emerging clinical use in tissue engineering. In: Domb AJ, Kumar N, Ezra A, eds. Biodegradable Polymers in Clinical Use and Clinical Development. New Jersey: Wiley, 2011: 6007.
  • 81
    Zink W, Graf BM. Local anesthetic myotoxicity. Regional Anesthesia and Pain Medicine 2004; 29: 33340.
  • 82
    Hogan Q, Dotson R, Erickson S, Kettler R, Hogan K. Local anesthetic myotoxicity: a case and review. Anesthesiology 1994; 80: 9427.
  • 83
    Carlson BM, Gutmann E. Free grafting of the extensor digitorum longus muscle in the rat after marcaine pretreatment. Experimental Neurology 1976; 53: 8293.
  • 84
    Zink W, Seif C, Bohl JR, et al. The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesthesia and Analgesia 2003; 97: 11739.
  • 85
    Benoit PW, Yagiela A, Fort NF. Pharmacologic correlation between local anesthetic-induced myotoxicity and disturbances of intracellular calcium distribution. Toxicology and Applied Pharmacology 1980; 52: 18798.
  • 86
    Foster AH, Carlson BM. Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesthesia and Analgesia 1980; 59: 72736.
  • 87
    Padera R, Bellas E, Tse JY, Hao D, Kohane DS. Local myotoxicity from sustained release of bupivacaine from microparticles. Anesthesiology 2008; 108: 9218.
  • 88
    Kalichman MW, Powell HC, Myers RR. Pathology of local anesthetic-induced nerve injury. Acta Neuropathologica 1988; 75: 5839.
  • 89
    Kalichman MW, Moorhouse DF, Powell HC, Myers RR. Relative neural toxicity of local anesthetics. Journal of Neuropathology and Experimental Neurology 1993; 52: 23440.
  • 90
    Bainton CR, Strichartz GR. Concentration dependence of lidocaine-induced irreversible conduction loss in frog nerve. Anesthesiology 1994; 81: 65767.
  • 91
    Sakura S, Bollen AW, Ciriales R, Drasner K. Local anesthetic neurotoxicity does not result from blockade of voltage-gated sodium channels. Anesthesia and Analgesia 1995; 81: 33846.
  • 92
    Karashima K, Taniguchi M, Nakamura T, et al. Prolongation of intrathecal and sciatic nerve blocks using a complex of levobupivacaine with maltosyl-beta-cyclodextrin in rats. Anesthesia and Analgesia 2007; 104: 11218.
  • 93
    Feldman HS, Dvoskin S, Halldin MH, Ask AL, Doucette AM. Comparative local anesthetic efficacy and pharmacokinetics of epidurally administered ropivacaine and bupivacaine in the sheep. Regional Anesthesia 1997; 22: 45160.